From where did the new coronavirus (nCoV, see box) arise, and how did it move to humans? How is it spreading and evolving? How can we develop therapies to treat it? SIB Groups provide a range of tools and resources that can help researchers answer these questions. These tools link viral epidemiology and genomics to protein sequences, variants, functions, and three-dimensional structures. Find out more about some of these tools below.
A new nCoV-dedicated page on ViralZone provides further biological insights, including a detailed comparison with the SARS virus’ genome as well as cross-links to complementary resources mentioned above. “We are highlighting specific differences between nCoV and SARS, in particular in its gene composition that seems closer to bat viruses and may explain the difference in pathogenicity and transmission”, explains Philippe Le Mercier who leads the developments of ViralZone at SIB’s Swiss-Prot Group.